Compared with patients without chronic kidney disease, patients with CKD are more likely to consume a limited number of fruits and vegetables, according to data published in the Journal of Renal Nutrition.
Investigators questioned if the low intake was a result or cause of CKD among these patients. Read more in Healio.
A population-based cohort study found that patients with chronic kidney disease (CKD) or who underwent a recent kidney transplant had a higher risk of cancer compared with people with normal kidney function.
A study published in American Journal of Kidney Diseases found that the risk of cancer was higher in patients with mild to moderate chronic kidney disease (CKD) and in kidney transplant recipients vs patients with normal kidney function. Patients with kidney disease also had a higher risk of cancer-related mortality.
Read more in the American Journal of Managed Care (AJMC).
— Severity of kidney disease ups risk of ICU time, in-hospital mortality, and more
SAN DIEGO — Certain factors were highly predictive of severe COVID illness in hospitalized patients who had type 2 diabetes (T2D) and chronic kidney disease (CKD), a researcher reported.
In a single-center study of patients with T2D and CKD hospitalized with COVID-19 infection, having hyperglycemia upon admission was tied with more than a 10 times higher risk of severe COVID illness (OR 10.49, 95% CI 3.09-35.60), according to Ella Burguera-Couce, an MD candidate at the Warren Alpert Medical School of Brown University in Providence, Rhode Island. Read the complete article in MedPage Today.
Patients with chronic kidney disease (CKD) may benefit considerably from supervised lifestyle therapies that increase physical activity and fitness. For a study, researchers conducted a randomized clinical study in 160 patients with stage 3–4 CKD to test the efficacy of a lifestyle intervention in improving cardiorespiratory fitness and exercise capacity over 36 months. Read more in Physician’s Weekly.
Patients with mild to moderate chronic kidney disease or recipients of kidney transplants are at increased risk for cancer, according to data published in the American Journal of Kidney Disease.
“We sought to characterize the burden of cancer diagnoses and cancer deaths among patients with kidney disease and determine whether their risk was increased vs. patients with normal kidney function,” Abhijat Kitchlu, MD, MSc, a staff nephrologist and clinician investigator at the University Health Network and an assistant professor of medicine at the University of Toronto, told Healio. “We also assessed whether patients with kidney disease were found to have more advanced cancer stage when they were diagnosed.”
Read the full story in Healio.
BOSTON — Patients with chronic kidney disease reported the COVID-19 pandemic negatively affected their mental health and quality of health care, according to a poster presented at the National Kidney Foundation Spring Clinical Meetings.
“We did a study to look at the impact of COVID-19 on mental health and the quality of health care in patients with diabetes,” Neil Roy, MBBS, from the Joslin Diabetes Center in Boston, told Healio. Read the full story in Healio.
Chronic kidney disease (CKD) is a progressive health condition that damages your kidneys. Your kidneys are two bean-shaped organs that help remove waste and excess fluid from the body.
High blood pressure and diabetes are the leading causes of CKD. Treating these conditions can help slow the progression of kidney damage. If your kidney function gets too low, you may need dialysis or a kidney transplant. Read more.
Malnutrition is associated with poor kidney function, increased risk of kidney function decline and chronic kidney disease among older adults without advanced kidney disease, according to data published in the Journal of Renal Nutrition.
Further, researchers noted that physicians might consider using preventative interventions to lower malnutrition risk (MR) among patients in this population. Read more.
Patients with chronic kidney disease are more willing to assume some risks of new medication as their disease advances, according to data published in Kidney Medicine.
Further, investigators found physicians might consider initiating risk vs. benefit conversations with patients when prescribing a new medication to slow disease progression. Read more.